Armistice Capital, Llc Avalo Therapeutics, Inc. (AVTX) insider trading activity

Armistice Capital, LLC is > 10% Shareholder of Avalo Therapeutics, Inc.. Currently has a direct ownership of 39.1 Million shares of AVTX, which is worth approximately $513 Million. The most recent transaction as insider was on May 31, 2019, when has been sold 13,800 shares (Common Stock) at a price of $4.91 per share, resulting in proceeds of $67,758. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.1M

0% 3M change

0% 12M change

Total Value Held $513 Million

ARMISTICE CAPITAL, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 31 2019	BUY Open market or private purchase	$67,758 $4.91 p/Share	13,800 Added 0.07%	18,414,285 Common Stock
May 30 2019	BUY Open market or private purchase	$84,448 $4.64 p/Share	18,200 Added 0.1%	18,400,485 Common Stock
May 29 2019	BUY Open market or private purchase	$87,970 $4.63 p/Share	19,000 Added 0.1%	18,382,285 Common Stock
May 28 2019	BUY Open market or private purchase	$17,220 $4.92 p/Share	3,500 Added 0.02%	18,363,285 Common Stock
May 24 2019	BUY Open market or private purchase	$57,114 $5.01 p/Share	11,400 Added 0.06%	18,359,785 Common Stock
May 23 2019	BUY Open market or private purchase	$71,205 $5.05 p/Share	14,100 Added 0.08%	18,348,385 Common Stock
May 17 2019	BUY Open market or private purchase	$9,583 $5.33 p/Share	1,798 Added 0.01%	18,334,285 Common Stock
May 16 2019	BUY Open market or private purchase	$42,240 $5.15 p/Share	8,202 Added 0.04%	18,332,487 Common Stock
May 14 2019	BUY Open market or private purchase	$25,870 $5.27 p/Share	4,909 Added 0.03%	18,324,285 Common Stock
May 13 2019	BUY Open market or private purchase	$61,047 $4.85 p/Share	12,587 Added 0.07%	18,319,376 Common Stock
May 10 2019	BUY Open market or private purchase	$12,395 $4.95 p/Share	2,504 Added 0.01%	18,306,789 Common Stock
Mar 27 2019	BUY Open market or private purchase	$54,800 $5.48 p/Share	10,000 Added 0.05%	18,304,285 Common Stock
Mar 26 2019	BUY Open market or private purchase	$88,984 $5.48 p/Share	16,238 Added 0.09%	18,294,285 Common Stock
Mar 25 2019	BUY Open market or private purchase	$74,315 $5.4 p/Share	13,762 Added 0.08%	18,278,047 Common Stock
Mar 08 2019	BUY Open market or private purchase	$21,840 $5.46 p/Share	4,000 Added 0.02%	18,264,285 Common Stock
Mar 07 2019	BUY Open market or private purchase	$32,640 $5.44 p/Share	6,000 Added 0.03%	18,260,285 Common Stock
Mar 06 2019	BUY Open market or private purchase	$690,173 $5.5 p/Share	125,486 Added 0.68%	18,254,285 Common Stock
Dec 31 2018	BUY Open market or private purchase	$39,114 $3.18 p/Share	12,300 Added 0.07%	18,128,799 Common Stock
Dec 28 2018	BUY Open market or private purchase	$82,677 $3.12 p/Share	26,499 Added 0.15%	18,116,499 Common Stock
Dec 18 2018	BUY Open market or private purchase	$23,269 $3.31 p/Share	7,030 Added 0.04%	18,090,000 Common Stock
Dec 17 2018	BUY Open market or private purchase	$48,698 $3.26 p/Share	14,938 Added 0.08%	18,082,970 Common Stock
Dec 14 2018	BUY Open market or private purchase	$93,347 $3.33 p/Share	28,032 Added 0.15%	18,068,032 Common Stock
Dec 10 2018	BUY Open market or private purchase	$46,418 $3.36 p/Share	13,815 Added 0.08%	18,040,000 Common Stock
Dec 07 2018	BUY Open market or private purchase	$21,215 $3.43 p/Share	6,185 Added 0.03%	18,026,185 Common Stock
Dec 06 2018	BUY Open market or private purchase	$56,580 $3.45 p/Share	16,400 Added 0.09%	18,020,000 Common Stock

Also insider at

BBI

Brickell Biotech, Inc. Healthcare

> 10% Shareholder

ALIM

ALIMERA SCIENCES INC Healthcare

> 10% Shareholder

KPRX

KIORA PHARMACEUTICALS INC Healthcare

> 10% Shareholder

SAVA

CASSAVA SCIENCES INC Healthcare

> 10% Shareholder

DFRG

Del Frisco's Restaurant Group, Inc.

> 10% Shareholder

VLRX

Valeritas Holdings Inc.

> 10% Shareholder

BPTH

BIO-PATH HOLDINGS INC Healthcare

> 10% Shareholder

AYTU

AYTU BIOPHARMA, INC Healthcare

Director

ACHV

ACHIEVE LIFE SCIENCES, INC. Healthcare

> 10% Shareholder

AMAG

AMAG PHARMACEUTICALS, INC.

> 10% Shareholder

RSLS

ReShape Weightloss Inc.

> 10% Shareholder

INNV

INNOVUS PHARMACEUTICALS, INC.

> 10% Shareholder

ONTX

Onconova Therapeutics, Inc. Healthcare

> 10% Shareholder

VXRT

Vaxart, Inc. Healthcare

Director

TTPH

TETRAPHASE PHARMACEUTICALS INC

Director

TENX

TENAX THERAPEUTICS, INC. Healthcare

Director

CYTH

Cyclo Therapeutics, Inc. Healthcare

> 10% Shareholder

RSLS

ReShape Lifesciences Inc. Healthcare

> 10% Shareholder

ACL